Preparing Patients for Radioiodine Treatment: Increasing Thyroid Cell Uptake and Accelerating the Excretion of Unbound Radioiodine

QR Code

Preparing Patients for Radioiodine Treatment: Increasing Thyroid Cell Uptake and Accelerating the Excretion of Unbound Radioiodine

None

Saved in:

Bibliographic Details
Main Author:	Matović, Milovan
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/33337
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Physiologic and False Positive Pathologic Uptakes on Radioiodine Whole Body Scan
by: Ahn, Byeong-Cheol
Published: (2011)

A practical approach on radioprotection in the treatment of radioiodine for thyroid cancer
by: Janaína Dutra Silvestre Mendes, et al.
Published: (2018-09-01)

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

Lenvatinib in advanced radioiodine-refractory differentiated thyroid cancer: what’s new?
by: E. V. Borodavina, et al.
Published: (2024-12-01)

Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy
by: Leo Hashimoto, et al.
Published: (2025-07-01)

Observation and treatment of patients with progressive metastatic differentiated thyroid cancer after establishment of radioiodine refractoriness
by: E. V. Borodavina, et al.
Published: (2024-08-01)

Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit
by: L. J. Wirth, et al.
Published: (2023-03-01)

Guidelines for radioiodine therapy in differentiated thyroid cancer and post-therapeutic follow-up
by: A. Yu. Shurinov, et al.
Published: (2024-06-01)

THE RESOLUTION OF THE EXPERT COUNCIL FOR TARGETED THERAPY OF RADIOIODINE REFRACTORY DIFFERENTIATED THYROID CANCER
by: . Expert Council
Published: (2015-04-01)

Advanced metastatic radioiodine refractory differentiated thyroid cancer: current treatment and dynamic surveillance issues
by: E. V. Borodavina, et al.
Published: (2025-03-01)

Selpercatinib in the treatment of medullary and radioiodine-refractory differentiated thyroid cancer with RET mutation (literature review)
by: E. V. Borodavina, et al.
Published: (2025-03-01)

RADIOIODINE THERAPY OF PAPILLARY THYROID CANCER, COMPLICATED BY A RADIAL MYELITIS. CLINICAL CASE
by: L. M. Farkhutdinova
Published: (2018-06-01)

Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer
by: M. E. Cabanillas, et al.
Published: (2020-02-01)

Metastases of papillary radioiodine-refractory thyroid cancer in the parapharyngeal lymph node: clinical case
by: N. A. Ognerubov, et al.
Published: (2021-04-01)

Clinical outcome and influencing factors of differentiated thyroid cancer patients with radioiodine-refractory lung metastasis
by: Congcong Wang, et al.
Published: (2025-08-01)

Labeling Peptides with Radioiodine: An Overview of Traditional and Emerging Techniques
by: Vincenzo Patamia, et al.
Published: (2025-07-01)

Personalized therapy with lenvatinib for progressive radioiodine refractory differentiated thyroid cancer in routine clinical practice
by: P. O. Rumyantsev, et al.
Published: (2021-11-01)

Follow-up after radioiodine remnant ablation in differentiated thyroid cancer: the view of nuclear medicine physician
by: A. Yu. Shurinov, et al.
Published: (2023-06-01)

“Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use
by: E. V. Borodavina, et al.
Published: (2024-04-01)

Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
by: M. S. Brose, et al.
Published: (2018-07-01)

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer
by: Jan Taprogge, et al.
Published: (2025-07-01)

The Impact of Radioiodine (131I) Therapy of Thyroid Disease on Salivary Glands Function and Inflammation: A Comprehensive Review
by: Pietro Bellini, et al.
Published: (2025-06-01)

Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation
by: E. V. Borodavina, et al.
Published: (2020-04-01)

Systemic Immune-Inflammation Index and Systemic Inflammation Response Index Predict the Response to Radioiodine Therapy for Differentiated Thyroid Cancer [Corrigendum]
by: Wang Y, et al.
Published: (2025-07-01)

Bilateral optic nerve swelling after thyroidectomy followed by a course of radioiodine therapy
by: E. E. Ioyleva, et al.
Published: (2018-02-01)

Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States
by: F. Worden, et al.
Published: (2025-07-01)

The utility of quantitative 18F-FDG PET/CT-derived parameters as prognostic factors for predicting overall survival in radioiodine-refractory differentiated thyroid cancer
by: Mai Son, et al.
Published: (2025-07-01)

<sup>18</sup>F-fluorodeoxyglucose positron emission tomography combined with computed tomography for the prediction of radioiodine therapy response in patients with metastatic differentiated thyroid cancer
by: T. M. Geliashvili, et al.
Published: (2020-02-01)

Complete remission of peritoneal strumosis from struma ovarii after radioiodine therapy: a case report
by: Jun Yang, et al.
Published: (2025-06-01)

Comparison of the Changes in Quality-of-Life of Cats with Hyperthyroidism Treated with Radioiodine or Antithyroid Drugs—A Preliminary Study
by: Fabienne Blunschi, et al.
Published: (2025-06-01)

Value of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in staging of patients with differentiated thyroid cancer after thyroidectomy during the first course of radioiodine therapy
by: T. M. Geliashvili, et al.
Published: (2021-01-01)

On the Decidability of Soundness of Workflow Nets with an Unbounded Resource
by: V. A. Bashkin, et al.
Published: (2013-08-01)

Hashimoto’s Thyroiditis – Interactions of Lymphocytes, Thyroid Cells and Fibroblasts
by: Iwona, Ben-Skowronek
Published: (2011)

On the Efficient Representation of an Unbounded Resource with the Aid of One-Counter Circuits
by: V. A. Bashkin
Published: (2013-04-01)

Boundedness of Variance Functions of Natural Exponential Families with Unbounded Support
by: Shaul K. Bar-Lev
Published: (2025-06-01)

Excretion of Steroid Hormones in Rodents: An Overview on Species Differences for New Biomedical Animal Research Models
by: Busso, Juan Manuel, et al.
Published: (2011)

Treatment Modalities in Thyroid Dysfunction
by: King, R., et al.
Published: (2012)

THE ASYMPTOTICS OF A SOLUTION OF THE MULTIDIMENSIONAL HEAT EQUATION WITH UNBOUNDED INITIAL DATA
by: Sergey V. Zakharov
Published: (2021-07-01)

Finite Element Modelling of a Flow-Acoustic Coupling in Unbounded Domains
by: Paweł ŁOJEK, et al.
Published: (2020-11-01)

Quadratic BSDEs with Singular Generators and Unbounded Terminal Conditions: Theory and Applications
by: Wenbo Wang, et al.
Published: (2025-07-01)